key: cord-0856707-8vem2l8l
authors: Lassen, Mats Christian Højbjerg; Skaarup, Kristoffer Grundtvig; Sengeløv, Morten; Iversen, Kasper; Ulrik, Charlotte Suppli; Jensen, Jens Ulrik Stæhr; Biering-Sørensen, Tor
title: Alcohol Consumption and the Risk of Acute Respiratory Distress Syndrome in COVID-19
date: 2021-06-01
journal: Annals of the American Thoracic Society
DOI: 10.1513/annalsats.202008-988rl
sha: 237d2fa1cbd6c2ddf449f11fd31262894d4eee0f
doc_id: 856707
cord_uid: 8vem2l8l

nan

We conducted a cohort study to understand the association of alcohol use and ARDS development using data from ECHOVID-19 (The COVID-19 Echocardiography Study), a prospective multicenter cohort study of 215 hospitalized patients with COVID-19 recruited from eight hospitals in eastern Denmark (March 30 to June 1, 2020). All patients were included consecutively with the investigators blinded to the health status of patients before inclusion. Inclusion criteria for ECHOVID-19 were laboratory-confirmed SARS-CoV-19 infection, age > 18 years, not admitted to an intensive care unit (ICU) at time of inclusion (patients were not excluded if later transferred to the ICU), and being capable of signing a written informed consent. Additional exclusion criteria for this substudy was an unknown history of alcohol consumption (N 5 44).

The primary outcome was ARDS (defined according to the Berlin Criteria) (5) during hospitalization. Severe ARDS, defined as ARDS with an arterial oxygen pressure/fraction of inspired oxygen ratio < 100 mm Hg, was a secondary outcome.

Information on alcohol consumption was obtained by a questionnaire. The exposure was defined as the continuous number of drinks of alcohol per week (12 g ethanol/drink). We used parametric and nonparametric tests to assess differences in baseline characteristics in relation to the outcome. Logistic regression models were used to test and visualize the association between alcohol consumption and the outcomes. A multivariable model was constructed to adjust for potential confounders of ARDS and severe ARDS development. The multivariable model included the variables: age, smoking status (ever-smoker vs. never-smoker), prevalent heart failure, and chronic obstructive pulmonary disease. All participants gave written informed consent, and the study was performed in accordance with the second Declaration of Helsinki and approved by the regional ethics board. The study is registered at Clinicaltrials.gov (NCT04377035).

A total of 171 patients were included in the final sample. The mean age of the study sample was 69 6 13 years and 55% were male. Baseline characteristics of patients progressing to ARDS and patients not developing ARDS are listed in Table 1 . During follow-up (median, 6 d; interquartile range [IQR], 4-11) 44 patients (25.7%) developed ARDS. Of these, 22 patients (12.9%) developed severe ARDS. ARDS was not observed significantly more frequently in patients excluded from the study sample (N 5 15 [34%]; P 5 0.27). The comparison of self-reported alcohol consumption revealed that patients developing ARDS consumed more drinks of alcohol per week than patients free of ARDS (7.0 drinks: IQR, 5.0-20.0 vs. 3.0 drinks: IQR, 2.0-8.0; P 5 0.010). In a univariable model, weekly alcohol consumption was associated with development of ARDS (odds ratio [OR], 1.06; 95% confidence interval [95% CI], 1.01-1.12; P 5 0.015, per 1-drink increase) and severe ARDS (OR, 1.07; 95% CI, 1.02-1.13; P 5 0.009) ( Figure 1) . The association between self-reported alcohol consumption and ARDS remained significant after multivariable adjustments (ARDS: OR, 1.05; 95% CI, 1.00-1.10; P 5 0.046, per 1 drink increase; severe ARDS: OR, 1.07; 95% CI, 1.01-1.13; P 5 0.013, per 1 drink increase).

In this study, weekly alcohol consumption was associated with an increased risk of developing ARDS during hospitalization for COVID-19. Higher alcohol consumption is known to be detrimental to health, but it may also be an indicator of psychosocial and socioeconomic challenges. Currently, there does not exist published literature regarding the prognosis after COVID-19 infection according to alcohol consumption. However, before the COVID-19 pandemic, Simou and colleagues conducted a review and metanalysis investigating the association between alcohol consumption and risk of ARDS in hospitalized adults (N 5 177,674) (6) . The authors found that chronic high alcohol consumption significantly increased the risk of ARDS. The increased risk of ARDS in excessive chronic alcohol consumption has been suggested to be caused by alcohol-induced oxidative stress leading to depletion of the critical antioxidant glutathione and ultimately deteriorates alveolar barrier integrity and modulation of the immune response (7) . Kim and colleagues (8) assessed the association between risk factors and ICU admission in 2,419 adults hospitalized with COVID-19. The authors found several risk factors and underlying conditions independently associated with ICU admission. The risk factors included obesity, immunosuppression, diabetes mellitus, and age (75-84 vs. 18-39 yr) with adjusted risk ratios of 1.31, 1.29, 1.31, and 1.84, respectively. In comparison, the adjusted OR of ARDS development for every 10 weekly drinks in our study was 1.64; 95% CI, 1.01-2.68; P 5 0.046. Thus, it seems that the association between weekly alcohol consumption and ARDS are within the same range as other risk factors known to be associated with a severe course of COVID-19. Naturally, there are several reservations when comparing risk ratios and odds ratios in addition to adjusted estimates of different studies.

We acknowledge that our findings are limited by the small sample size and should be further tested in larger cohorts. In addition, a limitation is that information on alcohol consumption is self-reported. Lastly, weekly alcohol consumption was missing for 20% of patients from the ECHOVID-19 study; however, we found an association of alcohol consumption with ARDS even though the included group of patients were probably less sick (less likely to develop ARDS) than the patients not able to provide information on weekly alcohol consumption. In conclusion, weekly alcohol consumption is associated with progression to ARDS during hospitalization with COVID-19. Assessing alcohol consumption habits in hospitalized COVID-19 may be useful for the identification of patients at increased risk of a poor in-hospital prognosis.

Author disclosures are available with the text of this letter at www.atsjournals.org. Among patients hospitalized with coronavirus disease (COVID-19) , 15-30% die during hospitalization (1-3). However, specific causes of death, the prevalence of organ system dysfunction before death, and features of end-of-life care in patients with COVID-19 remain unclear. Before the pandemic, in cohorts of patients who died during hospitalization for acute hypoxemic respiratory failure (AHRF), death was rarely due to refractory respiratory failure. Pulmonary dysfunction was the primary cause of death for only one in every five decedents and only 2% had insupportable oxygenation or ventilation (4, 5) . It is unknown whether causes and circumstances of death differ in patients with COVID-19-related respiratory failure versus historical cohorts with non-COVID-19-related respiratory failureand specifically whether death due to pulmonary dysfunction is more common with COVID-19.

We performed a retrospective cohort study of adult patients (aged >18 yr) hospitalized with a laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at Michigan Medicine (March 1 to June 30, 2020) who experienced in-hospital death. Michigan Medicine is a tertiary medical center with approximately 1,000 beds that treated hundreds of patients with COVID-19 during the 2020 spring surge. In April 2020, Michigan was the third leading state for COVID-19-related deaths. Throughout the pandemic, COVID-19 therapies were used at the discretion of the treating physician as supported by the best evidence available at the time; there was limited use of remdesivir, systemic corticosteroids, or therapeutic anticoagulation.

Clinical data for decedents were extracted from the medical record by two internal medicine-trained physicians using a structured abstraction tool. The data included organ system dysfunction, septic shock, the primary cause of death, and withdrawal of life support, using definitions adapted from previous studies (4, 5) . The primary organ system responsible for death was defined as the organ system dysfunction that most directly resulted in the patient's death or the decision to withdraw life support. This approach to adjudicating the primary cause of death had excellent interrater reliability in previous studies (5) , and there was full agreement between our abstractors on an initial set of 10 charts reviewed independently. Data on coinfection, goals-of-care discussions, advanced directives, spiritual support, respiratory support, and family presence at the time of death were also collected (6) . The study definitions are presented in Table 1 .

Finally, we compared causes of death with a previous cohort (5) of 385 patients admitted to Michigan Medicine with AHRF (January 1, 2016, to December 31, 2017) who experienced in-hospital death. We compared characteristics of patients with COVID-19 with patients with non-COVID-19-related respiratory failure using chisquare tests and considered P , 0.05 significant. Data analysis was completed in R. The study was deemed exempt by the University of Michigan Institutional Review Board.

We identified 82 decedents with COVID-19 who were 32.9% female and 43.9% Black and had a median age 71 (61-81) years ( Table 2) . The most common organ dysfunctions before death were pulmonary (81.7%), neurologic (57.3%), and renal (39.0%). Out of the total, 74.4% of patients were mechanically ventilated during hospitalization. A multiorgan failure occurred in 67.1% and coinfection occurred in 41.5%. Septic shock was present in 40.2% (24.3% with coinfection and 15.9% without coinfection).

The most common primary causes of death were pulmonary dysfunction (56.1%) and septic shock (26.8%). Compared with the Author Contributions: All authors made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and to drafting the work or revising it critically for important intellectual content; and provided final approval of the version submitted for publication; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work.

The impact of alcohol-related diagnoses on pneumonia outcomes

Alcohol and the risk of pneumonia: a systematic review and meta-analysis

Coronavirus disease 2019 hangover: a rising tide of alcohol use disorder and alcohol-associated liver disease

Are patients with alcohol use disorders at increased risk for COVID-19 infection?

ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition

The effect of alcohol consumption on the risk of ARDS: a systematic review and meta-analysis

Chronic-alcohol-abuse-induced oxidative stress in the development of acute respiratory distress syndrome